Forum

The purpose of RDAF is to serve as a platform to exchange ideas and define actions to raise awareness of rare diseases and to improve access to treatment and patient care in Switzerland.

 

RDAF brings together experts in the field of rare diseases.

Board

Fürst-Ladani, Shayesteh; President (SFL Pharma)

Karg, Saskia  (Universitäts-Kinderspital Zürich)

Kessler, Reto (Vertex)

Lal, Rea (Pfizer)

Morneau, Pierre (Takeda)

de Sá, Jacqueline (ProRaris)

Schupp, Robert (Santhera)

Secretariat

Rare Disease Action Forum

c/o SFL Regulatory Affairs & Scientific Communication GmbH

Margarethenstrasse 47-49, CH-4053 Basel, Schweiz

info@rda-forum.org